← Open Payments lookup

ANCY TOM: Open Payments

NPI 1669840203 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,887 in 177 payments from 18 companies in 2025. Trend: 2023 $683 · 2024 $1,952 · 2025 $3,887

Food & beverage: $3,776Education: $111
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)19$539
Otsuka America Pharmaceutical, Inc.27$528
E.R. Squibb & Sons, L.L.C.17$437
ABBVIE INC.22$408
Alkermes, Inc.13$343
Teva Pharmaceuticals USA, Inc.14$326
Vanda Pharmaceuticals Inc.10$293
Salix Pharmaceuticals, a division of Bausch Health US, LLC13$267
Neurocrine BioSciences, Inc.10$177
Lundbeck LLC12$175

Products named: REXULTI, CAPLYTA, COBENFY, VRAYLAR, ARISTADA, FANAPT, RELISTOR, INGREZZA.

Industry payments across NV — which companies pay providers there.